A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer

M. Elvington, Y.X. Huang, B.P. Morgan, F. Qiao, N. van Rooijen, C. Atkinson, S. Tomlinson

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)6043-6051
JournalBlood
Volume119
Issue number25
DOIs
Publication statusPublished - 2012

Cite this

Elvington, M., Huang, Y. X., Morgan, B. P., Qiao, F., van Rooijen, N., Atkinson, C., & Tomlinson, S. (2012). A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. Blood, 119(25), 6043-6051. https://doi.org/10.1182/blood-2011-10-383232